Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 3/20 | 0.70 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | ANPEP | P15144 | 1/20 | 0.56 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA6 | P23280 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.55 |
| ▸ | MEP1B | Q16820 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.53 |
| ▸ | MEP1A | Q16819 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30395109 | 0.96 | FOLH1 (0.66) | FOLH1CYP2D6CYP2C9HIF1AANPEP | |
| SCHEMBL1817886 | 0.96 | FOLH1 (0.66) | FOLH1CYP2D6CYP2C9HIF1AANPEP | |
| SCHEMBL1296456 | 0.92 | FOLH1 (0.61) | FOLH1CYP2D6CYP2C9HIF1AANPEP | |
| SCHEMBL16559877 | 0.91 | FOLH1 (0.66) | FOLH1CYP2D6CYP2C9HIF1AANPEP | |
| Hydrochloric Acid SCHEMBL7138106 | 0.90 | FOLH1 (0.59) | FOLH1CYP2D6CYP2C9HIF1AANPEP | |
| SCHEMBL27705266 | 0.90 | FOLH1 (0.59) | FOLH1CYP2D6CYP2C9HIF1AANPEP | |
| SCHEMBL334419 | 0.90 | CYP4F2 (0.64) | FOLH1CYP2D6CYP2C9HIF1AANPEP | |
| SCHEMBL27705268 | 0.89 | FOLH1 (0.58) | FOLH1CYP2D6CYP2C9HIF1AANPEP | |
| SCHEMBL13811862 | 0.89 | FOLH1 (0.58) | FOLH1CYP2D6CYP2C9HIF1AANPEP | |
| SCHEMBL27705270 | 0.89 | FOLH1 (0.58) | FOLH1CYP2D6CYP2C9HIF1AANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 526 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014004146-A1 | SILICONE RUBBER | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-01-03 | — | — | WO | claimed |
| JP-58126314-A | — | — | None | — | — | JP | disclosed |
| JP-56131659-A | — | — | None | — | — | JP | disclosed |
| JP-56050954-A | — | — | None | — | — | JP | disclosed |
| JP-56030428-A | — | — | None | — | — | JP | disclosed |
| JP-56131623-A | — | — | None | — | — | JP | disclosed |
| US-12622673-B2 | Ultrasonic probe | TICONA LLC (US) | 2026-05-12 | — | — | US | disclosed |
| EP-4735508-A2 | SUSTAINABLE, HIGH FLOW LIQUID CRYSTALLINE POLYMER COMPOSITION | Ticona LLC (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20260098124-A1 | Bio-Dihydroxyphenols for Use in Forming Bio-Liquid Crystalline Polymers | TICONA LLC (US) | 2026-04-09 | — | — | US | disclosed |
| EP-4716952-A1 | A SUPERCONDUCTING CABLE SYSTEM | Supernode Ltd (IE) | 2026-04-01 | — | — | EP | disclosed |
| US-20020061844-A1 | Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt | ILEXUS PTY LIMITED | 2002-05-23 | — | — | US | disclosed |
| EP-1195408-A1 | LIQUID-CRYSTAL POLYESTER RESIN COMPOSITION | KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUSHO (JP) | 2002-04-10 | — | — | EP | disclosed |
| EP-1195398-A1 | LIQUID-CRYSTAL POLYESTER RESIN | KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUSHO (JP) | 2002-04-10 | — | — | EP | disclosed |
| US-6355683-B1 | ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASE | ILEXUS PTY LIMITED (AU) | 2002-03-12 | — | — | US | disclosed |
| WO-2001087829-A1 | BISACYLGUANIDINE | MERCK PATENT GMBH (DE) | 2001-11-22 | — | — | WO | disclosed |
| JP-S58126314-A | POLYESTER FIBER AND PREPARATION THEREOF | TEIJIN LTD | 1983-07-27 | — | — | JP | disclosed |
| JP-S56131659-A | CARBON FIBER-REINFORCED POLYESTER MOLDING COMPOUND | TORAY IND INC | 1981-10-15 | — | — | JP | disclosed |
| JP-S56131623-A | POLYESTER MOLDED PRODUCT | TORAY IND INC | 1981-10-15 | — | — | JP | disclosed |
| JP-S5650954-A | GLASS FIBER-REINFORCED POLYESTER MOLDING MATERIAL | TORAY IND INC | 1981-05-08 | — | — | JP | disclosed |
| JP-S5630428-A | PREPARATION OF COPOLYMERIZED POLYESTER | TORAY IND INC | 1981-03-27 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020061844-A1 | Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt | FCGR2A, FCGR1A, FCER2 | FOLH1 600/4885CYP2D6 981/4885CYP2C9 1013/4885 |
| US-12622673-B2 | Ultrasonic probe | IKBKE, HCK, IKBKB | FOLH1 4801/4885CYP2D6 1509/4885CYP2C9 2081/4885 |
| US-20260098124-A1 | Bio-Dihydroxyphenols for Use in Forming Bio-Liquid Crystalline Polymers | HAO2, HAAO, HPD | FOLH1 3733/4885CYP2D6 70/4885CYP2C9 459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.